Filana Therapeutics, Inc. Warrants and Rights Outstanding
Filana Therapeutics, Inc. (FLNA) had Warrants and Rights Outstanding of $0 as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2026-03-12
- 2024-09-30: Warrants and Rights Outstanding $0.00.
- 2024-01-02: Warrants and Rights Outstanding $113.36M; Warrants and Rights Outstanding as first filed $113.36K.
| Period end | Warrants and Rights Outstanding | Warrants and Rights Outstanding as first filed |
|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | |
| 2024-01-02 | $113.36M 10-K · filed 2026-03-12 | $113.36K 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |